A prominent exchange-traded fund (ETF) provider is making a calculated move within the burgeoning weight loss drug market, showcasing a long-term vision that extends beyond the current industry leaders. The recently launched GLP-1 & Weight Loss ETF (OZEM) takes a unique approach by pairing established pharmaceutical giants with companies developing novel treatments for both weight … Weight Loss Industry’s Next Chapter: ETF Taps into Long-Term Potential Beyond Initial Boom
The post Weight Loss Industry’s Next Chapter: ETF Taps into Long-Term Potential Beyond Initial Boom appeared first on ImaStockTrader.